In a randomized, dounble-blind clinical trial, we have shown that the innovative Sucrosomial B12 formulation rapidly achieve considerably higher and maintained circulatory B12 levels, overcoming the deficiency-borderline threshold (200300 pg/mL) within 24 h with a single 1,000 g dose
Our peptides are made in the USA so they meet the highest standards of quality and purity
Pharmacological Reports , 2018 While oral use may not be optimal for musculoskeletal repair, it remains a popular option for gastrointestinal recovery and chronic inflammatory conditions
Gradual loading prevents re-injury and improves tissue tolerance
Reconstitution and dosing depend on the exact product, concentration, pharmacy instructions, and prescribing guidance
Gene expression profile of prostate cancer patients by chemiluminescent analysis